• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超重的慢性阻塞性肺疾病急性加重(AECOPD)患者的临床特征。

Clinical Characteristics of Overweight Patients With Acute Exacerbation Chronic Obstructive Pulmonary Disease (AECOPD).

机构信息

Department of Pulmonary and Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.

Department of Pulmonary and Critical Care Medicine, Suining Central Hospital, Suining, Sichuan, China.

出版信息

Clin Respir J. 2024 Aug;18(8):e70001. doi: 10.1111/crj.70001.

DOI:10.1111/crj.70001
PMID:39187923
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11347388/
Abstract

INTRODUCTION

Low body weight in patients with COPD is associated with a poor prognosis and more comorbidities. However, the impact of increased body weight in patients with COPD remains controversial. The aim of this study was to explore the clinical features of overweight patients with AECOPD.

METHODS

In this multicenter cross-sectional study, a total of 647 AECOPD patients were recruited. Finally, 269 normal weight and 162 overweight patients were included. Baseline characteristics and clinical and laboratory data were collected. The least absolute shrinkage and selection operator (LASSO) regression was performed to determine potential features, which were substituted into binary logistic regression to reveal overweight-associated clinical features. The nomogram and its associated curves were established to visualize and verify the logistic regression model.

RESULTS

Six potential overweight-associated variables were selected by LASSO regression. Subsequently, a binary logistic regression model identified that the rates of type 2 diabetes (T2DM) and hypertension and levels of lymphocytes (LYM)%, and alanine aminotransferase (ALT) were independent variables of overweight in AECOPD patients. The C-index and AUC of the ROC curve of the nomogram were 0.671 and 0.666, respectively. The DCA curve revealed that the nomogram had more clinical benefits if the threshold was at a range of 0.22~0.78.

CONCLUSIONS

Collectively, we revealed that T2DM and hypertension were more common, and LYM% and ALT were higher in AECOPD patients with overweight than those with normal weight. The result suggests that AECOPD patients with overweight are at risk for additional comorbidities, potentially leading to worse outcomes.

摘要

简介

COPD 患者体重偏低与预后不良和更多合并症相关。然而,COPD 患者体重增加的影响仍存在争议。本研究旨在探讨 AECOPD 超重患者的临床特征。

方法

本多中心横断面研究共纳入 647 例 AECOPD 患者,最终纳入 269 例体重正常和 162 例超重患者。收集基线特征、临床和实验室数据。采用最小绝对收缩和选择算子(LASSO)回归确定潜在特征,将其代入二项逻辑回归揭示与超重相关的临床特征。建立列线图及其相关曲线,以可视化和验证逻辑回归模型。

结果

LASSO 回归选择了 6 个潜在的超重相关变量。随后,二元逻辑回归模型确定 2 型糖尿病(T2DM)和高血压的发生率以及淋巴细胞(LYM)%和丙氨酸氨基转移酶(ALT)水平是 AECOPD 患者超重的独立变量。列线图的 C 指数和 AUC 分别为 0.671 和 0.666。ROC 曲线的 DCA 曲线显示,如果阈值在 0.22~0.78 范围内,列线图具有更多的临床获益。

结论

总的来说,我们发现与体重正常的 AECOPD 患者相比,超重患者的 T2DM 和高血压更为常见,LYM%和 ALT 水平更高。这表明 AECOPD 超重患者存在发生额外合并症的风险,可能导致预后更差。

相似文献

1
Clinical Characteristics of Overweight Patients With Acute Exacerbation Chronic Obstructive Pulmonary Disease (AECOPD).超重的慢性阻塞性肺疾病急性加重(AECOPD)患者的临床特征。
Clin Respir J. 2024 Aug;18(8):e70001. doi: 10.1111/crj.70001.
2
Risk factors for hyponatremia in acute exacerbation chronic obstructive pulmonary disease (AECOPD): a multicenter cross-sectional study.急性加重期慢性阻塞性肺疾病(AECOPD)患者低钠血症的危险因素:一项多中心横断面研究。
BMC Pulm Med. 2023 Jan 28;23(1):39. doi: 10.1186/s12890-023-02328-4.
3
A Diagnostic Nomogram for Predicting Hypercapnic Respiratory Failure in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.用于预测慢性阻塞性肺疾病急性加重患者高碳酸血症性呼吸衰竭的诊断列线图。
Int J Chron Obstruct Pulmon Dis. 2024 May 18;19:1079-1091. doi: 10.2147/COPD.S454558. eCollection 2024.
4
Machine learning reveals sex differences in clinical features of acute exacerbation of chronic obstructive pulmonary disease: A multicenter cross-sectional study.机器学习揭示慢性阻塞性肺疾病急性加重期临床特征的性别差异:一项多中心横断面研究。
Front Med (Lausanne). 2023 Mar 28;10:1105854. doi: 10.3389/fmed.2023.1105854. eCollection 2023.
5
Emergency admission parameters for predicting in-hospital mortality in patients with acute exacerbations of chronic obstructive pulmonary disease with hypercapnic respiratory failure.预测伴有高碳酸血症呼吸衰竭的慢性阻塞性肺疾病急性加重患者住院死亡率的急诊入院参数。
BMC Pulm Med. 2021 Aug 6;21(1):258. doi: 10.1186/s12890-021-01624-1.
6
Development and Validation of an In-Hospital Mortality Prediction Model for Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病急性加重患者住院死亡率预测模型的建立与验证。
Int J Chron Obstruct Pulmon Dis. 2024 Jun 12;19:1303-1314. doi: 10.2147/COPD.S461269. eCollection 2024.
7
[Risk Factors and a Prediction Model for Frequent Acute Exacerbations of Chronic Obstructive Pulmonary Disease].[慢性阻塞性肺疾病频繁急性加重的危险因素及预测模型]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024 Aug;46(4):519-527. doi: 10.3881/j.issn.1000-503X.15981.
8
Analysis of prevalence and prognosis of type 2 diabetes mellitus in patients with acute exacerbation of COPD.分析 COPD 急性加重期患者 2 型糖尿病的患病率及预后。
BMC Pulm Med. 2021 Jan 6;21(1):7. doi: 10.1186/s12890-020-01371-9.
9
Evaluation of Blood Markers at Admission for Predicting Community Acquired Pneumonia in Chronic Obstructive Pulmonary Disease.入院时血液标志物评估对慢性阻塞性肺疾病社区获得性肺炎的预测作用。
COPD. 2021 Oct;18(5):557-566. doi: 10.1080/15412555.2021.1976739. Epub 2021 Sep 12.
10
Construction and validation of risk prediction model for deep vein thrombosis in acute exacerbations of chronic obstructive pulmonary disease based on serum angiopoietin 2 levels.基于血清血管生成素 2 水平的慢性阻塞性肺疾病急性加重期深静脉血栓形成风险预测模型的构建与验证。
Ann Palliat Med. 2021 Jul;10(7):7905-7918. doi: 10.21037/apm-21-1448.

本文引用的文献

1
Machine learning reveals sex differences in clinical features of acute exacerbation of chronic obstructive pulmonary disease: A multicenter cross-sectional study.机器学习揭示慢性阻塞性肺疾病急性加重期临床特征的性别差异:一项多中心横断面研究。
Front Med (Lausanne). 2023 Mar 28;10:1105854. doi: 10.3389/fmed.2023.1105854. eCollection 2023.
2
Risk factors for hyponatremia in acute exacerbation chronic obstructive pulmonary disease (AECOPD): a multicenter cross-sectional study.急性加重期慢性阻塞性肺疾病(AECOPD)患者低钠血症的危险因素:一项多中心横断面研究。
BMC Pulm Med. 2023 Jan 28;23(1):39. doi: 10.1186/s12890-023-02328-4.
3
Risk Factors for Length of Hospital Stay in Acute Exacerbation Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Study.
慢性阻塞性肺疾病急性加重期住院时间的危险因素:一项多中心横断面研究
Int J Gen Med. 2022 Mar 29;15:3447-3458. doi: 10.2147/IJGM.S354748. eCollection 2022.
4
Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss.非酒精性脂肪性肝病(NAFLD):病理生理学、临床管理和减肥效果的综述。
BMC Endocr Disord. 2022 Mar 14;22(1):63. doi: 10.1186/s12902-022-00980-1.
5
The interplay between diabetes mellitus and chronic obstructive pulmonary disease.糖尿病与慢性阻塞性肺疾病的相互作用。
Minerva Med. 2023 Feb;114(1):68-73. doi: 10.23736/S0026-4806.22.07742-4. Epub 2022 Feb 9.
6
Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations.肥胖症、代谢综合征与癌症:病理生理学与治疗相关性。
Endocrine. 2021 Dec;74(3):478-497. doi: 10.1007/s12020-021-02884-x. Epub 2021 Oct 8.
7
Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease.糖尿病中的高血压:基础机制和临床疾病的更新。
Hypertension. 2021 Nov;78(5):1197-1205. doi: 10.1161/HYPERTENSIONAHA.121.17981. Epub 2021 Oct 4.
8
Obesity: Epidemiology, Pathophysiology, and Therapeutics.肥胖症:流行病学、病理生理学与治疗学。
Front Endocrinol (Lausanne). 2021 Sep 6;12:706978. doi: 10.3389/fendo.2021.706978. eCollection 2021.
9
Development and Validation of Prognostic Nomograms for Elderly Patients with Osteosarcoma.老年骨肉瘤患者预后列线图的开发与验证
Int J Gen Med. 2021 Sep 14;14:5581-5591. doi: 10.2147/IJGM.S331623. eCollection 2021.
10
SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications.SGLT2 抑制剂和 GLP-1 受体激动剂:已确立和新兴的适应证。
Lancet. 2021 Jul 17;398(10296):262-276. doi: 10.1016/S0140-6736(21)00536-5. Epub 2021 Jun 30.